[SY8-4] Update on secondary CNS relapse in diffuse large B-cell lymphoma: Who is ‘high risk’? Optimal prophylaxis?
Dr. Kerry J. Savage is a Medical Oncologist at BC Cancer and a Professor of Medicine at the University of British Columbia (UBC). She received a BSc and a M.D. from UBC. She completed an Internal Medicine residency at the University of Western Ontario and a Medical Oncology residency at BC Cancer. She completed a post-doctoral research fellowship in lymphoma at the Dana-Farber Cancer Institute and earned a MSc in Epidemiology from the Harvard School of Public Health.
Dr. Savage is active in clinical trials in lymphoma and melanoma and involved in translational research. She is the Clinical Lead for the lymphoma and melanoma Clinical Trials Unit. Her main areas of research focus are peripheral T-cell lymphomas, Hodgkin lymphoma, primary mediastinal large B-cell lymphoma and investigating predictors of central nervous system relapse in diffuse large B-cell lymphoma.
Dr. Savage is active in clinical trials in lymphoma and melanoma and involved in translational research. She is the Clinical Lead for the lymphoma and melanoma Clinical Trials Unit. Her main areas of research focus are peripheral T-cell lymphomas, Hodgkin lymphoma, primary mediastinal large B-cell lymphoma and investigating predictors of central nervous system relapse in diffuse large B-cell lymphoma.
Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.Password is written on a program book.